Literature DB >> 24997148

Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study.

Khaled M Musallam1, Maria Domenica Cappellini2, Shahina Daar3, Mehran Karimi4, Amal El-Beshlawy5, Giovanna Graziadei2, Matthew Magestro6, Jerome Wulff7, Guilhem Pietri7, Ali T Taher8.   

Abstract

Entities:  

Keywords:  complications; iron overload; thalassemia

Mesh：

Substances：

Year:  2014        PMID： 24997148      PMCID： PMC4222462          DOI： 10.3324/haematol.2013.097220

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

Review 1.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

2.  Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia.

Authors:  Khaled M Musallam; Maria Domenica Cappellini; John C Wood; Irene Motta; Giovanna Graziadei; Hani Tamim; Ali T Taher
Journal:  Haematologica       Date:  2011-07-26       Impact factor: 9.941

Review 3.  Iron overload in non-transfusion-dependent thalassemia: a clinical perspective.

Authors:  Khaled M Musallam; Maria D Cappellini; John C Wood; Ali T Taher
Journal:  Blood Rev       Date:  2012-04       Impact factor: 8.250

4.  Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia.

Authors:  Khaled M Musallam; Maria Domenica Cappellini; Ali T Taher
Journal:  Blood Cells Mol Dis       Date:  2013-02-18       Impact factor: 3.039

Review 5.  Iron overload in β-thalassemia intermedia: an emerging concern.

Authors:  Khaled M Musallam; Maria D Cappellini; Ali T Taher
Journal:  Curr Opin Hematol       Date:  2013-05       Impact factor: 3.284

Review 6.  Non-transfusion-dependent thalassemias.

Authors:  Khaled M Musallam; Stefano Rivella; Elliott Vichinsky; Eliezer A Rachmilewitz
Journal:  Haematologica       Date:  2013-06       Impact factor: 9.941

7.  Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study.

Authors:  Ali T Taher; John Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Jacqueline Ros; Yiyun Zhang; Dany Habr; Maria Domenica Cappellini
Journal:  Blood       Date:  2012-05-15       Impact factor: 22.113

Review 8.  Treating iron overload in patients with non-transfusion-dependent thalassemia.

Authors:  Ali T Taher; Vip Viprakasit; Khaled M Musallam; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

9.  Deferasirox effectively reduces iron overload in non-transfusion-dependent thalassemia (NTDT) patients: 1-year extension results from the THALASSA study.

Authors:  Ali T Taher; John B Porter; Vip Viprakasit; Antonis Kattamis; Suporn Chuncharunee; Pranee Sutcharitchan; Noppadol Siritanaratkul; Renzo Galanello; Zeynep Karakas; Tomasz Lawniczek; Dany Habr; Jacqueline Ros; Zewen Zhu; M Domenica Cappellini
Journal:  Ann Hematol       Date:  2013-06-18       Impact factor: 3.673
  9 in total
  13 in total

Review 1.  Management of non-transfusion-dependent thalassemia: a practical guide.

Authors:  Ali T Taher; Maria Domenica Cappellini
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

2.  Impact of HFE-2 and HAMP Gene Variations on Iron Overload in Pediatric Patients with Non-Transfusion Dependent Thalassemia: A Pilot Study.

Authors:  Niteesh Bharadwaj; Srinivasan Peyam; Prateek Bhatia; Anmol Bhatia; Reena Das; Minu Singh; Deepak Bansal; Amita Trehan; Richa Jain
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-07       Impact factor: 0.900

3.  Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.

Authors:  John B Porter; Maria Domenica Cappellini; Antonis Kattamis; Vip Viprakasit; Khaled M Musallam; Zewen Zhu; Ali T Taher
Journal:  Br J Haematol       Date:  2016-12-05       Impact factor: 6.998

Review 4.  Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia.

Authors:  Rayan Bou-Fakhredin; Abdul-Hamid Bazarbachi; Bachar Chaya; Joseph Sleiman; Maria Domenica Cappellini; Ali T Taher
Journal:  Int J Mol Sci       Date:  2017-12-20       Impact factor: 5.923

Review 5.  Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

Authors:  Joseph Sleiman; Ali Tarhini; Rayan Bou-Fakhredin; Antoine N Saliba; Maria Domenica Cappellini; Ali T Taher
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

Review 6.  Non-deletional alpha thalassaemia: a review.

Authors:  Ibrahim Kalle Kwaifa; Mei I Lai; Sabariah Md Noor
Journal:  Orphanet J Rare Dis       Date:  2020-06-29       Impact factor: 4.123

Review 7.  Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series.

Authors:  Valeria Maria Pinto; Gian Luca Forni
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

8.  Correlation of Serum Ferritin and Liver Iron Concentration with Transient Liver Elastography in Adult Thalassemia Intermedia Patients with Blood Transfusion.

Authors:  Tubagus Djumhana Atmakusuma; Anna Mira Lubis
Journal:  J Blood Med       Date:  2021-04-15

9.  The Correlation between Serum Level of Leptin and Troponin in Children with Major Beta-Thalassemia.

Authors:  I Shahramian; N M Noori; A Teimouri; E Akhlaghi; E Sharafi
Journal:  Iran J Ped Hematol Oncol       Date:  2015-03-15

Review 10.  Modified Le Fort I Osteotomy and Genioplasty for Management of Severe Dentofacial Deformity in β-Thalassaemia Major: Case report and review of the literature.

Authors:  Khamis M Al Hasani; Abdulaziz A Bakathir; Ahmed K Al-Hashmi; Badar Al Rawahi; Abdullah Albakri
Journal:  Sultan Qaboos Univ Med J       Date:  2020-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.